EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of macrophage migration inhibitory factor family and CD74 in the pathogenesis of melanoma

Keiji Tanese, Dai Ogata

Experimental Dermatology · 2024-06 · 33 (6)

DOI: 10.1111/exd.15122 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Experimental Dermatology, online erschienen am 17.06.2024. Verfasst von Keiji Tanese und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Toho University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Melanoma, Macrophage Migration-Inhibitory Factors, Antigens, Differentiation, B-Lymphocyte, Histocompatibility Antigens Class II. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 147 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is an aggressive tumour with poor prognosis that arises from the malignant transformation of melanocytes. Over the past few decades, intense research into the pathogenesis of melanoma has led to the development of BRAF and immune checkpoint inhibitors, including antibodies against programmed cell death protein 1 (PD‐1) and cytotoxic T lymphocyte‐associated protein 4 (CTLA‐4), which have shown clinically significant efficacy. However, some tumours do not respond to these therapies initially or become treatment resistant. Most melanoma tissues appear to possess biological characteristics that allow them to evade these treatments, and identifying these characteristics is one of the major challenges facing cancer researchers. One such characteristic that has recently gained attention is the role of macrophage migration inhibitory factor (MIF) and its receptor CD74. This review outlines the cellular and molecular functions of CD74, MIF and their family of proteins. We then review their roles in tumours based on previous reports, highlight their pathological significance in melanoma and discuss their potential as therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaMacrophage Migration-Inhibitory FactorsAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIIntramolecular OxidoreductasesHumansSkin NeoplasmsAnimals

Stichwörter der Autor:innen

CD74macrophage migration inhibitory factormelanoma

Substanzen

Macrophage Migration-Inhibitory FactorsAntigens, Differentiation, B-Lymphocyteinvariant chainHistocompatibility Antigens Class IIIntramolecular OxidoreductasesMIF protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Toho University School of Medicine, Tokyo, Japan.
  • Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.

Zitieren

APA

Tanese, K., & Ogata, D. (2024). The role of macrophage migration inhibitory factor family and CD74 in the pathogenesis of melanoma. Experimental Dermatology, 33(6). https://doi.org/10.1111/exd.15122

Vancouver

Tanese K, Ogata D. The role of macrophage migration inhibitory factor family and CD74 in the pathogenesis of melanoma. Experimental Dermatology. 2024;33(6). doi:10.1111/exd.15122

BibTeX
@article{Tanese2024,
  author = {Tanese, Keiji and Ogata, Dai},
  title = {The role of macrophage migration inhibitory factor family and CD74 in the pathogenesis of melanoma},
  journal = {Experimental Dermatology},
  year = {2024},
  volume = {33},
  number = {6},
  doi = {10.1111/exd.15122}
}
Kostenlos starten →